C. ROYO-CEBRECOS Et Al. , "Impact of the inclusion of an aminoglycoside in the initial empirical antibiotic therapy of haematologic neutropenic patients with Gram-negative bacteraemia in an era of widespread antimicrobial resistance (AMINOLACTAM study)," 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , Spain, 2018
ROYO-CEBRECOS, C. Et Al. 2018. Impact of the inclusion of an aminoglycoside in the initial empirical antibiotic therapy of haematologic neutropenic patients with Gram-negative bacteraemia in an era of widespread antimicrobial resistance (AMINOLACTAM study). 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , (Spain).
ROYO-CEBRECOS, C., GUİDOL, C., AYAZ CEYLAN, Ç. M., PUERTA, P., TORRES, D., MARTİN-DAVİLA, P., ... ESCRİHUELA-VİDAL, F.(2018). Impact of the inclusion of an aminoglycoside in the initial empirical antibiotic therapy of haematologic neutropenic patients with Gram-negative bacteraemia in an era of widespread antimicrobial resistance (AMINOLACTAM study) . 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Spain
ROYO-CEBRECOS, CRİSTİNA Et Al. "Impact of the inclusion of an aminoglycoside in the initial empirical antibiotic therapy of haematologic neutropenic patients with Gram-negative bacteraemia in an era of widespread antimicrobial resistance (AMINOLACTAM study)," 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Spain, 2018
ROYO-CEBRECOS, CRİSTİNA Et Al. "Impact of the inclusion of an aminoglycoside in the initial empirical antibiotic therapy of haematologic neutropenic patients with Gram-negative bacteraemia in an era of widespread antimicrobial resistance (AMINOLACTAM study)." 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , Spain, 2018
ROYO-CEBRECOS, C. Et Al. (2018) . "Impact of the inclusion of an aminoglycoside in the initial empirical antibiotic therapy of haematologic neutropenic patients with Gram-negative bacteraemia in an era of widespread antimicrobial resistance (AMINOLACTAM study)." 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) , Spain.
@conferencepaper{conferencepaper, author={CRİSTİNA ROYO-CEBRECOS Et Al. }, title={Impact of the inclusion of an aminoglycoside in the initial empirical antibiotic therapy of haematologic neutropenic patients with Gram-negative bacteraemia in an era of widespread antimicrobial resistance (AMINOLACTAM study)}, congress name={28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)}, city={}, country={Spain}, year={2018}}